Alger
Alger Small Cap Focus Fund
US Small-cap
Dec 2024 → Sep 2026
Our archive holds 7 letters from this strategy, behind 7 investment theses and positions in 12 companies. Every quote below is copied verbatim from the letter it came from.
7 letters in 3 years · follow all of Alger for every strategy.
Performance
as of Sep 30, 2026 · net of fees · USD · Class A
- YTD+17.5%index +10.7%
- 1Y+21.8%index +12.1%
- 3Y · /yr+17.3%index +17.6%
- 5Y · /yr−3.2%index +4.7%
- 10Y · /yr+8.6%index +9.9%
- Inception · /yr+8.3%index +9.7%
Index: Russell 2000 Growth Index
| YTD | 1Y | 3Yper year | 5Yper year | 10Yper year | Since inceptionper year | |
|---|---|---|---|---|---|---|
| Alger Small Cap Focus Fund | +17.5% | +21.8% | +17.3% | −3.2% | +8.6% | +8.3% |
| Russell 2000 Growth Index | +10.7% | +12.1% | +17.6% | +4.7% | +9.9% | +9.7% |
Disclaimer
These figures are copied from the manager’s latest letter, as of Sep 30, 2026. They were extracted automatically, have not been verified by HF Best Ideas and may contain errors. They cover a single share class, in the currency and fee basis stated above; other share classes and your own returns will differ. This is not investment advice, nor an offer to buy or sell any fund. Past performance does not predict future returns.
Read full disclosures →Also held
- Twist Bioscience Corp.
- VSE Corporation
- Cardinal Infrastructure Group, Inc.
- Adaptive Biotechnologies Corp.
- RBC Bearings Incorporated
- Guardant Health, Inc.
- Karman Holdings Inc.
- Blue Origin Enterprises, L.P.
- GeneDx Holdings Corp.
- Boehringer Ingelheim Group
- Forte Biosciences Inc.
- Nebius Group N.V.
- Credo Technology Group Holding Ltd.
Its investment theses
- Twist Bioscience Corp.Sep 2026Twist Bioscience manufactures custom DNA at scale and is seen as well positioned to benefit from AI-driven drug discovery demand and accelerating orders.
- Adaptive Biotechnologies Corp.Sep 2026Adaptive Biotechnologies develops immune-system diagnostics and is supported by improving results, a path to profitability, and broader clinical adoption of clonoSEQ.
- Cardinal Infrastructure Group, Inc.Sep 2026Cardinal Infrastructure provides site-development services and is viewed as having a durable growth opportunity due to project management, customer relationships, and market expansion.
- RBC Bearings IncorporatedSep 2026RBC Bearings makes engineered bearings and motion-control components and is supported by engineering expertise, pricing power, recurring demand, and long-term aerospace and defense opportunities.
- VSE CorporationSep 2026VSE Corporation provides aviation services and is viewed as attractive due to aging fleets, outsourcing demand, expanding repair capabilities, and efficiency gains from integration.
- Credo Technology Group Holding Ltd.Jun 2026Credo Technology supplies high-speed connectivity products for AI data centers, benefiting from rapid growth and expanding product capabilities.
- Clearwater AnalyticsJun 2025Clearwater Analytics is a leading cloud-based investment analytics provider that, despite recent share price weakness due to debt concerns from acquisitions, has the potential for transformational growth and strengthened market position.